Skip to main content
Premium Trial:

Request an Annual Quote

Thanks for the Feedback

On his blog, DrugMonkey discusses the argument that junior reviewers become bogged down in the details in study sections and don't focus on the quality of the science. DrugMonkey says some of these complaints may be due to how less established scientists think or are taught study sections and reviews should go, based upon the feedback they have themselves received. "Is it any wonder they direct the same critiques at the applications they review?" asks DrugMonkey.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.